Abstract
THE heterotrimeric G proteins mediate a variety of cellular processes by coupling transmembrane receptors to different effector molecules, including adenylyl cyclases and inositol-phospholipid-specific phospholipase C (PLC)1–3. Activation of adenylyl cyclases results in the production of cyclic AMP and activation of cAMP-dependent protein kinase (PKA). Phospholipase C catalyses the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdInsP2) to generate diacylglycerol and inositol-1,4,5-triphosphate (InsP3), leading to the activation of protein kinase C (PKC) and the mobilization of intracellular calcium4. The various PLC isoforms appear to be activated by different receptors, and in some cases by different G-protein components5. There are four well-characterized forms of PLC-β and all of them are activated to various extents by the Gαq family of G proteins6–9. Specific activation of PLC isoforms β2 and β3 by; G-protein βγ subunits has also been reported10,11. Although it has been suggested that PLC activity might be modulated by the adenylyl cyclase pathway, no clear link has been established between the two pathways. Here we report that cAMP-dependent protein kinase specifically inhibits Gβγ-activated PLC-β2 activity but not that of the Gα-activated PLC isoforms, and that the effect of PKA is not mimicked by PKC isozymes. Furthermore, we show that PKA directly phosphorylates serine residues of the PLC-β2 protein both in vivo and in vitro. Our results provide an insight into the specificity and nature of the crosstalk between the two G-protein-coupled signal transduction pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gilman, A. G. A. Rev. Biochem. 56, 615–649 (1987).
Simon, M. I., Strathmann, M. P. & Gautam, N. Science 252, 802–808 (1991).
Neer, E. J. Cell 80, 249–257 (1995).
Berridge, M. J. Nature 361, 315–325 (1993).
Rhee, S. G. & Choi, K. D. J. biol. Chem. 267, 12393–12396 (1992).
Smrcka, A. V., Hepler, J. R., Brown, K. O. & Sternweis, P. C. Science 251, 804–807 (1991).
Taylor, S. J., Chae, H. Z., Rhee, S. G. & Exton, J. H. Nature 350, 516–518 (1991).
Jhon, D. Y. et al. J. biol. Chem. 268, 6654–6661 (1993).
Jiang, H. P., Wu, D. & Simon, M. I. J. biol. Chem. 269, 7593–7596 (1994).
Camps, M. et al. Nature 360, 684–688 (1992).
Katz, A., Wu, D. & Simon, M. I. Nature 360, 686–689 (1992).
Uhler, M. D. et al. Proc. natn. Acad. Sci. U.S.A. 83, 1300–1304 (1986).
Dekker, L. V. & Parker, P. J. Trends biochem. Sci. 19, 73–77 (1994).
Ryu, S. H. et al. J. biol. Chem. 265, 17941–17945 (1990).
Offermanns, S. & Simon, M. I. J. biol. Chem. 270, 15175–15180 (1995).
Wu, D., LaRosa, G. J. & Simon, M. I. Science 261, 101–103 (1993).
Watson, S. P., McConnell, R. T. & Lipetina, E. G. J. biol. Chem. 259, 13199–13203 (1984).
Hall, I. P., Donaldson, J. & Hill, S. J. Br. J. Pharmac. 100, 646–650 (1990).
Takenawa, T., Ishitoya, J. & Nagai, Y. J. biol. Chem. 261, 1092–1098 (1986).
Neylon, C. D. & Summers, R. J. Eur. J. Pharmac. 148, 441–444 (1988).
Madison, J. M. & Brown, J. K. J. clin. invest. 82, 1462–1465 (1988).
Perney, T. M. & Miller, R. J. J. biol. Chem. 264, 7317–7327 (1989).
Okajima, F. & Kondo, Y. J. biol. Chem. 270, 26332–26340 (1995).
Snyderman, R., Perlanin, A., Evans, T., Polakis, P. & Didsburg, J. in ADP-ribosylating Toxin and G Proteins (eds Moss, J. & Vaughan M.) 295–323 (Am. Soc. Microbiol., Washington DC, 1990).
Wu, D., Katz, A. & Simon, M. I. Proc. natn. Acad. Sci. U.S.A. 90, 5297–5301 (1993).
Wu, D., Jiang, H., Katz, A. & Simon, M. I. J. biol. Chem. 268, 3704–3709 (1993).
Anwer, K., Hovington, J. A. & Sanborn, B. M. Endrocrinology 124, 2995–3002 (1989).
Wen, Y., Anwer, K., Singh, S. P. & Sanborn, B. M. Endocrinology 131, 1377–1382 (1992).
Kim, U. H., Kim, J. W. & Rhee, S. G. J. biol. Chem. 264, 20167–20170 (1989).
Richardson, R. M., Ali, H., Tomhave, E. D., Haribabu, B. & Snyderman, R. J. biol. Chem. 270, 27829–27833 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, M., Simon, M. Regulation by cAMP-dependent protein kinease of a G-protein-mediated phospholipase C. Nature 382, 83–87 (1996). https://doi.org/10.1038/382083a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/382083a0
This article is cited by
-
cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology—tribute to Karl H. Jakobs
Naunyn-Schmiedeberg's Archives of Pharmacology (2019)
-
Physiological crosstalk between the AC/PKA and PLC/PKC pathways modulates melatonin-mediated, monochromatic-light-induced proliferation of T-lymphocytes in chickens
Cell and Tissue Research (2017)
-
Mitochondrial cAMP signaling
Cellular and Molecular Life Sciences (2016)
-
Regulation of Gβγi-Dependent PLC-β3 Activity in Smooth Muscle: Inhibitory Phosphorylation of PLC-β3 by PKA and PKG and Stimulatory Phosphorylation of Gαi-GTPase-Activating Protein RGS2 by PKG
Cell Biochemistry and Biophysics (2014)
-
Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation
Basic Research in Cardiology (2011)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
